Storia in 20 fonti

Rasonque gets US nod: The pill that nearly doubles pancreatic cancer survival — and is set to $475,000 a year

US FDA cleared Rasonque, the first drug to block RAS, the mutation behind most pancreatic cancers. In trials it took median survival from 6.7 months to 13.2.

Raccontata da

jpost.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

hindustantimes.comStai leggendo16 h fa

Rasonque gets US nod: The pill that nearly doubles pancreatic cancer survival — and is set to $475,000 a year

US FDA cleared Rasonque, the first drug to block RAS, the mutation behind most pancreatic cancers. In trials it took median survival from 6.7 months to 13.2.

originale

Timeline cronologica

martedì 25 agosto 2026·letemps.ch
L’Agence américaine du médicament approuve le Rasonque, traitement très prometteur contre le cancer du pancréas - Le Temps
Le médicament utilisant le daraxonrasib vient d’être autorisé sur le sol américain, pour un coût de traitement d’environ de 40 000 dollars par mois. Des essais cliniques…
mercoledì 26 agosto 2026·forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.

Rasonque gets US nod: The pill that nearly doubles pancreatic cancer survival — and is set to $475,000 a year

Confronto fonti

Rasonque gets US nod: The pill that nearly doubles pancreatic cancer survival — and is set to $475,000 a year

Timeline cronologica

L’Agence américaine du médicament approuve le Rasonque, traitement très prometteur contre le cancer du pancréas - Le Temps

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

A pill that doubles survival: Revolution's FDA-approved drug gives pancreatic cancer patients a fighting…

FDA approves pancreatic cancer drug that nearly doubles survival time

FDA approves landmark pancreatic cancer drug

FDA approves new drug Rasonque to treat advanced pancreatic cancer

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

FDA approves breakthrough pancreatic cancer drug proven to extend survival

Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger bet | Fortune

FDA approves new pancreatic cancer drug that could extend patients' lives